American Beacon ARK Transformational Innovation Fund
Not enough financial coverage to compute a composite score for ADNRX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companyamericanbeaconfunds.com/products/mutual-funds/american-beacon-ark-transformational-innovation-fund/adnrx
Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are principally in developed markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities.
- IPO
- 2020
- HQ
- Fort Worth, TX, US
Price Chart
Performance & Tape
- 52W High
- $25.06
- 52W Low
- $15.34
- 50D MA
- $20.40
- 200D MA
- $21.43
- Beta
- 2.33
- Avg Volume
- 0
Get TickerSpark's AI analysis on ADNRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ADNRX Coverage
We haven't published any research on ADNRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ADNRX Report →